Connect with us

otc

CPSM, Inc. (SWMM: OTCQB) | CPSM, Inc. Q3 Growth Only Slowed By Hurricane Irma

Published

on

STUART, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) — CPSM, Inc. (OTCQB:SWMM), the Florida based pool & spa industry aggregator, released its third quarter and nine-month results with continued value growth.

CPSM reported an increase of year over year Tradebuddy.onlineholders’ Equity of approximately 18% over the same period in the prior year while retained earnings continues to swell. Revenue grew approximately 3% over the prior nine months moderated by the impact felt during the Hurricane Irma clean up.

Chairman Lawrence Calarco, commented, “Hurricane Irma disrupted our higher margin work in the third quarter. We temporarily reassigned our renovation crews to clean up and maintenance. Getting our customers’ property back to normal was a priority. No business was lost due to the interruption though, the results we reported did reflect this delay.  The Company has a continued focus on customer satisfaction and growing shareholder value.”  

CPSM, Inc. is a publicly held company serving the surging pool/spa maintenance, design, and construction industry.

Safe Harbor Statement: This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

SOURCE: CPSM, Inc.

CONTACT:
Jeff Michel
Director
CPSM, Inc.
Email : info@cpsm-inc.com
www.cpsm-inc.com
www.cpoolplastering.com
www.custompoolmechanics.com

Copyright © 2017 GlobeNewswire. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

otc

Orexo AB (ORXOY: OTCQX International) | Orexo completes early redemption of existing bond loan

Published

on

 

 

Orexo completes early redemption of existing bond loan

Nov 22, 2017

OTC Disclosure & News Service

Stockholm, Uppsala, Sweden

This release includes additional documents. Select the link(s) below to view.

Press release Orexo completes early redemption of existing bond loan publ. 22.11.2017.pdf

Copyright © 2017 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Continue Reading

otc

Orexo AB (ORXOY: OTCQX International) | Orexo Completes Early Redemption of Existing Bond Loan

Published

on

UPPSALA, Sweden, Nov. 22, 2017 /PRNewswire/ — Orexo AB (publ.) (the “Company”) today announces that the Company, in accordance with Orexo’s press release on 31 October 2017, has completed the early total redemption of the existing bond loan (ISIN SE0005932159).

The redemption was made at an amount corresponding to 101 percent of the nominal amount (i.e. SEK 1,010,000 per bond, the nominal amount being SEK 1,000,000) together with accrued but unpaid interest from the preceding interest payment date on November 9 2017 up to, and including, the redemption date on November 22 2017. In conjunction herewith, the bonds are delisted from the corporate bond list of Nasdaq Stockholm.

For further information, please contact:

Orexo AB   (publ.)

Nikolaj Sørensen, President and CEO                         
Tel: +46 (0)18-780-88-00                                              
E-mail: ir@orexo.com                                                   

Henrik Juuel, EVP and CFO
Tel: + 46 (0)18-780-88-00
E-mail: ir@orexo.com

About Orexo

Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but the aim is to address therapeutic areas where our competence and technologies can create value. The main market today is the US market for the treatment of opioid dependence where the product Zubsolv® is commercialized by Orexo. Other products are commercialized by license partners, including Zubsolv in markets outside of the US. Total net sales for 2016 amounted to SEK 705.9 million and the number of employees was 102. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) index and is available as ADRs on OTCQX (ORXOY) in the US. The head office, where also research and development is performed, is located in Uppsala, Sweden.

For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on Twitter, @orexoabpubl, LinkedIn and YouTube. For more information about Zubsolv in the US, see the product and market websites www.zubsolv.com  and www.rise-us.com

The information was submitted for publication at 8:30 am CET, November 22, 2017

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/orexo/r/orexo-completes-early-redemption-of-existing-bond-loan,c2396751

The following files are available for download:

 

View original content:http://www.prnewswire.com/news-releases/orexo-completes-early-redemption-of-existing-bond-loan-300560846.html

SOURCE Orexo

Copyright © 2017 PR Newswire. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Continue Reading

Recent Posts

Trending